FDA OTHER_CORRESPONDENCE - Novartis Gene Therapies, Inc. - August 02, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This OTHER CORRESPONDENCE record concerns Novartis Gene Therapies, Inc., with an inspection on August 2, 2019, issued by the Office of Biological Product Operations, covering biologics.

Company: Novartis Gene Therapies, Inc.
Inspection Date: August 2, 2019
Product Type: Biologics
Office: Office of Biological Product Operations
People: Scott T. Ballard
Ashar Parikh Investigator
Mihaly S. Ligmond (CSO)
David G (Acting Chief Scientist)

Open in Dashboard

ID · e848efbe-98af-4b81-a414-7d8ed0d1aa0e

Violation Codes1

21 CFR 210

Full citation text and observation details available on the Dashboard.